Wendy W. Hwang-Verslues, Ph.D. - Publications

Affiliations: 
2007 University of California, Riverside, Riverside, CA, United States 
Area:
Molecular Biology

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Cheung SK, Chuang PK, Huang HW, Hwang-Verslues WW, Cho CH, Yang WB, Shen CN, Hsiao M, Hsu TL, Chang CF, Wong CH. Stage-specific embryonic antigen-3 (SSEA-3) and β3GalT5 are cancer specific and significant markers for breast cancer stem cells. Proceedings of the National Academy of Sciences of the United States of America. PMID 26677875 DOI: 10.1073/pnas.1522602113  0.96
2015 Wu HH, Hwang-Verslues WW, Lee WH, Huang CK, Wei PC, Chen CL, Shew JY, Lee EY, Jeng YM, Tien YW, Ma C, Lee WH. Targeting IL-17B-IL-17RB signaling with an anti-IL-17RB antibody blocks pancreatic cancer metastasis by silencing multiple chemokines. The Journal of Experimental Medicine. 212: 333-49. PMID 25732306 DOI: 10.1084/jem.20141702  0.96
2013 Hwang-Verslues WW, Chang PH, Jeng YM, Kuo WH, Chiang PH, Chang YC, Hsieh TH, Su FY, Lin LC, Abbondante S, Yang CY, Hsu HM, Yu JC, Chang KJ, Shew JY, et al. Loss of corepressor PER2 under hypoxia up-regulates OCT1-mediated EMT gene expression and enhances tumor malignancy. Proceedings of the National Academy of Sciences of the United States of America. 110: 12331-6. PMID 23836662 DOI: 10.1073/pnas.1222684110  0.96
2012 Chang PH, Hwang-Verslues WW, Chang YC, Chen CC, Hsiao M, Jeng YM, Chang KJ, Lee EY, Shew JY, Lee WH. Activation of Robo1 signaling of breast cancer cells by Slit2 from stromal fibroblast restrains tumorigenesis via blocking PI3K/Akt/β-catenin pathway. Cancer Research. 72: 4652-61. PMID 22826604 DOI: 10.1158/0008-5472.CAN-12-0877  0.96
2011 Hwang-Verslues WW, Chang PH, Wei PC, Yang CY, Huang CK, Kuo WH, Shew JY, Chang KJ, Lee EYHP, Lee WH. MiR-495 is upregulated by E12/E47 in breast cancer stem cells, and promotes oncogenesis and hypoxia resistance via downregulation of E-cadherin and REDD1 Oncogene. 30: 2463-2474. PMID 21258409 DOI: 10.1038/onc.2010.618  0.96
2010 Hwang-Verslues WW, Sladek FM. HNF4α--role in drug metabolism and potential drug target? Current Opinion in Pharmacology. 10: 698-705. PMID 20833107 DOI: 10.1016/j.coph.2010.08.010  0.96
2010 Bolotin E, Liao H, Ta TC, Yang C, Hwang-Verslues W, Evans JR, Jiang T, Sladek FM. Integrated approach for the identification of human hepatocyte nuclear factor 4alpha target genes using protein binding microarrays. Hepatology (Baltimore, Md.). 51: 642-53. PMID 20054869 DOI: 10.1002/hep.23357  0.96
2009 Hwang-Verslues WW, Kuo WH, Chang PH, Pan CC, Wang HH, Tsai ST, Jeng YM, Shew JY, Kung JT, Chen CH, Lee EY, Chang KJ, Lee WH. Multiple lineages of human breast cancer stem/progenitor cells identified by profiling with stem cell markers. Plos One. 4: e8377. PMID 20027313 DOI: 10.1371/journal.pone.0008377  0.96
2008 Hwang-Verslues WW, Chang KJ, Lee EY, Lee WH. Breast cancer stem cells and tumor suppressor genes. Journal of the Formosan Medical Association = Taiwan Yi Zhi. 107: 751-66. PMID 18926942 DOI: 10.1016/S0929-6646(08)60188-6  0.96
2008 Hwang-Verslues WW, Sladek FM. Nuclear receptor hepatocyte nuclear factor 4alpha1 competes with oncoprotein c-Myc for control of the p21/WAF1 promoter. Molecular Endocrinology (Baltimore, Md.). 22: 78-90. PMID 17885207 DOI: 10.1210/me.2007-0298  0.96
2006 Maeda Y, Hwang-Verslues WW, Wei G, Fukazawa T, Durbin ML, Owen LB, Liu X, Sladek FM. Tumour suppressor p53 down-regulates the expression of the human hepatocyte nuclear factor 4alpha (HNF4alpha) gene. The Biochemical Journal. 400: 303-13. PMID 16895524 DOI: 10.1042/BJ20060614  0.96
Show low-probability matches.